CoLucid Pharmaceuticals Announces Achievement of Secondary Endpoints in SAMURAI
Sep 17, 2016 09:30 am UTC| Business
100 mg and 200 mg doses of lasmiditan were more efficacious than placebo on headache pain relief at the two-hour time point (p 0.001)100 mg and 200 mg doses of lasmiditan were more efficacious than placebo as rescue...
Sep 17, 2016 02:07 am UTC| Business
NEW ORLEANS, Sept. 16, 2016 -- Kahn Swick Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 14, 2016 to file lead...
Sep 17, 2016 02:07 am UTC| Business
NEW ORLEANS, Sept. 16, 2016 -- Kahn Swick Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 3, 2016 to file lead plaintiff...
Sep 17, 2016 02:07 am UTC| Business
NEW ORLEANS, Sept. 16, 2016 -- Kahn Swick Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 8, 2016 to file lead plaintiff...
Sep 16, 2016 23:53 pm UTC| Business
NEW YORK, Sept. 16, 2016 -- Pomerantz LLP announces that a class action lawsuit has been filed against AECOM (“AECOM” or the “Company”) (NYSE:ACM) and certain of its officers. The class action, filed in United States...
Sep 16, 2016 23:45 pm UTC| Business
NEW YORK, Sept. 16, 2016 -- Pomerantz LLP announces that a class action lawsuit has been filed against American Renal Associates Holdings, Inc. (“American Renal” or the “Company”) (NYSE:ARA) and certain of its officers....
Sep 16, 2016 23:45 pm UTC| Business
NEW YORK, Sept. 16, 2016 -- Pomerantz LLP announces that a class action lawsuit has been filed against Signet Jewelers Ltd. (“Signet” or the “Company”) (NYSE:SIG) and certain of its officers. The class action, filed in...